| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.431 | 27.240 | 2.145 | 924 | 1.043 | 6.536 | 60.354 | 102.576 | 112.410 | 129.139 |
| Total Income - EUR | 23.370 | 27.252 | 2.150 | 924 | 1.043 | 6.536 | 60.354 | 102.577 | 112.410 | 129.206 |
| Total Expenses - EUR | 22.664 | 26.628 | 2.044 | 856 | 187 | 6.312 | 56.478 | 81.253 | 99.086 | 112.254 |
| Gross Profit/Loss - EUR | 706 | 624 | 106 | 68 | 856 | 224 | 3.876 | 21.324 | 13.324 | 16.953 |
| Net Profit/Loss - EUR | 33 | 92 | 41 | 41 | 825 | 86 | 3.397 | 20.654 | 12.559 | 13.657 |
| Employees | 1 | 1 | 1 | 0 | 0 | 1 | 2 | 4 | 3 | 4 |
Check the financial reports for the company - Bavaria Clinic Biolife S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.911 | 12.857 | 12.517 | 12.167 | 11.813 | 11.531 | 11.276 | 11.957 | 13.026 | 12.152 |
| Current Assets | 4.587 | 2.370 | 2.259 | 2.226 | 3.221 | 3.317 | 23.598 | 31.963 | 42.253 | 59.278 |
| Inventories | 2.653 | 0 | 239 | 0 | 0 | 142 | 4.059 | 0 | 0 | 0 |
| Receivables | 676 | 223 | 304 | 215 | 211 | 1.509 | 10.256 | 18.699 | 24.947 | 19.171 |
| Cash | 1.258 | 2.148 | 1.716 | 2.012 | 3.010 | 1.665 | 9.283 | 13.264 | 17.306 | 40.107 |
| Shareholders Funds | 2.013 | 2.085 | 2.090 | 2.092 | 2.877 | 3.092 | 6.420 | 27.094 | 39.570 | 53.006 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | 3.514 | 13.142 | 65 | -88 | 7 | -25 | 17.169 | 5.643 | 4.328 | 7.206 |
| Income in Advance | 12.970 | 12.838 | 12.621 | 12.389 | 12.149 | 11.919 | 11.655 | 11.691 | 11.655 | 11.590 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Bavaria Clinic Biolife S.r.l.